Cardiovascular & Metabolic

Urocortin

Urocortin 1/2/3 (UCN)

A family of CRH-related peptides with cardioprotective, anti-inflammatory, and stress-modulating properties. Urocortin 2 and 3 are being studied for heart failure treatment.

CardiovascularStressCRH-relatedHeart FailureAnti-inflammatory

Quick Reference

Category
Cardiovascular & Metabolic
Research Claims
3 reviewed
Explore Research

Mechanism of Action

Urocortins bind to CRH-R1 and CRH-R2 receptors. CRH-R2 activation (Urocortin 2/3) produces cardioprotection, vasodilation, and anti-inflammatory effects without the anxiogenic effects of CRH-R1 activation.

Health Claims & Evidence

Cardioprotective and positive inotropic effects

ModerateCRH-R2 activation improves cardiac function in animal models

Anti-inflammatory effects

ModerateCRH-R2-mediated anti-inflammatory signaling documented

Reduces stress-induced cardiac damage

Moderatecardioprotection against ischemia-reperfusion injury documented

Short-Term Effects

Improved cardiac function, vasodilation.

Long-Term Effects

Research use primarily.

Side Effects

Limited human data.

Contraindications

Limited human safety data.

This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.

Research Papers

Urocortin and cardiac protection

Brar et al. · Circulation · 2004

Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.

Related Peptides

Explore the research further

Our AI Research Advisor can help you explore the evidence on Urocortin and related peptides, and prepare an educational research summary.

Explore Research